OR5M9

Across TCGA pan-cancer cohorts, OR5M9 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated OR5M9 data layer compared with 7 for mutation status.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher OR5M9 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR5M9 expression acts as an unfavorable survival marker, although some lineages such as ESCA and GBM show a favorable association.

UCS, MESO, and UCEC are the cancer types where OR5M9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	All	0.104	0.688	<.001	108	view →
MESO	OS	Tertile	All	0.148	0.569	<.001	108	view →
UCEC	DFS	Tertile	All	0.205	0.659	.001	78	view →
STAD	DFS	Tertile	All	0.274	0.727	<.001	45	view →
BLCA	OS	Tertile	IV	0.120	0.599	<.001	36	view →
ESCA	OS	Tertile	III,IV	1.000	0.367	.021	30	view →
SKCM	DFS	Tertile	III,IV	0.046	0.648	<.001	27	view →
GBM	OS	Tertile	All	0.602	0.387	.011	27	view →
LAML	DFS	Tertile	All	0.026	0.572	<.001	18	view →
LIHC	OS	Tertile	II,III,IV	0.152	0.614	.049	9	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

OR5M9–UCS (OS)

Open the UCS breakdown →